Immunomedics Inc (NASDAQ:IMMU)

15.61
Delayed Data
As of May 17
 -0.45 / -2.80%
Today’s Change
11.55
Today|||52-Week Range
27.33
+9.39%
Year-to-Date

Today’s Trading

Previous close16.06
Today’s open15.82
Day’s range15.59 - 16.19
Volume2,226,267
Average volume (3 months)3,117,186
Market cap$3.0B
Data as of 4:00pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)-13.77%
Earnings growth (this year)+8.55%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book11.14

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp-1.24-2.06%
QDELQuidel Corp-0.90-1.58%
--Quidel Corp-0.49-0.98%
MYGNMyriad Genetics Inc-0.41-1.55%
Data as of 4:00pm ET, 05/17/2019

Financials

Next reporting dateAugust 28, 2019
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$157.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Financial &
Business Officer
Usama Malik
Chief Technology Officer
Morris Z. Rosenberg
Corporate headquarters
Morris Plains, New Jersey

Forecasts